The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...

There remains a need for organizations and stakeholders to develop guidance for prescribing ketamine as a pain treatment.

This monograph details the clinical efficacy and safety of TNX-102 SL, a sublingual formulation of cyclobenzaprine that targets nonrestorative sleep and modulates centralized pain, as a treatment for ...

Current Evidence-Based Airway Management in Pediatric Anesthesia Clinical research has created evidence-based guidelines and approaches to pediatric airway management that will improve outcomes. JULY ...

Anesthesiology News, now in its 48th year, has been the most widely read publication for the specialty for the last 25 years.